• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

亚洲假药青蒿琥酯致人死亡——非洲会步其后尘吗？

Manslaughter by fake artesunate in Asia--will Africa be next?

作者信息

Newton Paul N, McGready Rose, Fernandez Facundo, Green Michael D, Sunjio Manuela, Bruneton Carinne, Phanouvong Souly, Millet Pascal, Whitty Christopher J M, Talisuna Ambrose O, Proux Stephane, Christophel Eva Maria, Malenga Grace, Singhasivanon Pratap, Bojang Kalifa, Kaur Harparkash, Palmer Kevin, Day Nicholas P J, Greenwood Brian M, Nosten François, White Nicholas J

机构信息

Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom.

出版信息

PLoS Med. 2006 Jun;3(6):e197. doi: 10.1371/journal.pmed.0030197.

DOI:10.1371/journal.pmed.0030197
PMID:16752952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1475657/
Abstract

Fake artesunate could compromise the hope that artemisinin-based combination therapy offers for malaria control in Africa and Asia.

摘要

假冒青蒿琥酯可能会损害以青蒿素为基础的联合疗法为非洲和亚洲疟疾防治带来的希望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d634/1479409/88d91a74682d/pmed.0030197.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d634/1479409/693ca8cc2f03/pmed.0030197.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d634/1479409/88d91a74682d/pmed.0030197.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d634/1479409/693ca8cc2f03/pmed.0030197.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d634/1479409/88d91a74682d/pmed.0030197.g002.jpg

相似文献

1
Manslaughter by fake artesunate in Asia--will Africa be next?亚洲假药青蒿琥酯致人死亡——非洲会步其后尘吗？
PLoS Med. 2006 Jun;3(6):e197. doi: 10.1371/journal.pmed.0030197.
2
Counterfeit artemisinin derivatives and Africa: update from authors.假冒青蒿素衍生物与非洲：作者最新情况汇报
PLoS Med. 2007 Mar 27;4(3):e139. doi: 10.1371/journal.pmed.0040139.
3
A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia.一项针对东南亚非法假冒青蒿琥酯贸易的联合流行病学调查。
PLoS Med. 2008 Feb;5(2):e32. doi: 10.1371/journal.pmed.0050032.
4
Fake artesunate in southeast Asia.东南亚的假冒青蒿琥酯。
Lancet. 2001 Jun 16;357(9272):1948-50. doi: 10.1016/S0140-6736(00)05085-6.
5
WHO, the Global Fund, and medical malpractice in malaria treatment.世界卫生组织、全球基金与疟疾治疗中的医疗事故
Lancet. 2004 Jan 17;363(9404):237-40. doi: 10.1016/S0140-6736(03)15330-5.
6
Global fund changes tack on malaria therapy.全球基金改变疟疾治疗策略。
Nature. 2004 Jun 10;429(6992):588. doi: 10.1038/429588a.
7
Estimating the needs for artesunate-based combination therapy for malaria case-management in Africa.估算非洲基于青蒿琥酯的联合疗法用于疟疾病例管理的需求。
Trends Parasitol. 2003 Aug;19(8):363-9. doi: 10.1016/s1471-4922(03)00168-5.
8
Artemisinin-based combination treatment for malaria in Africa: no perfect solutions.非洲基于青蒿素的疟疾联合治疗：没有完美的解决方案。
Clin Infect Dis. 2005 Oct 15;41(8):1087-8. doi: 10.1086/444464. Epub 2005 Sep 13.
9
Artemisinin combination therapies.青蒿素联合疗法
Lancet. 2006 Jun 24;367(9528):2037-9. doi: 10.1016/S0140-6736(06)68900-9.
10
Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials.东南亚地区的假冒抗疟药是疟疾防控的主要障碍：关于假冒抗疟药流行情况的多国横断面调查
Trop Med Int Health. 2004 Dec;9(12):1241-6. doi: 10.1111/j.1365-3156.2004.01342.x.

引用本文的文献

1
Towards malaria elimination and its implication for vector control, disease management and livelihoods in Tanzania.迈向疟疾消除及其对坦桑尼亚病媒控制、疾病管理和生计的影响。
Malariaworld J. 2013 Dec 12;4:19. doi: 10.5281/zenodo.10928325. eCollection 2013.
2
Nondestructive Measurement Technique for Substandard Amoxicillin Based on Thermal Approach.基于热分析方法的不合格阿莫西林无损检测技术
ACS Omega. 2024 Apr 18;9(17):19378-19384. doi: 10.1021/acsomega.4c00536. eCollection 2024 Apr 30.
3
Forensic investigation of falsified antimalarials using isotope ratio mass spectrometry: a pilot investigation.

本文引用的文献

1
Characterization of solid counterfeit drug samples by desorption electrospray ionization and direct-analysis-in-real-time coupled to time-of-flight mass spectrometry.通过解吸电喷雾电离和实时直接分析与飞行时间质谱联用对固体假药样品进行表征。
ChemMedChem. 2006 Jul;1(7):702-5. doi: 10.1002/cmdc.200600041.
2
Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6.恶性疟原虫野外分离株对体外蒿甲醚的抗性及SERCA型PfATPase6的点突变
Lancet. 2005 Dec 3;366(9501):1960-3. doi: 10.1016/S0140-6736(05)67787-2.
3
Versatile new ion source for the analysis of materials in open air under ambient conditions.
利用同位素比质谱法对伪造抗疟药物进行法医调查：一项初步调查。
Sci Rep. 2024 Feb 18;14(1):3995. doi: 10.1038/s41598-024-54168-9.
4
Environmental DNA as an innovative technique to identify the origins of falsified antimalarial tablets-a pilot study of the pharmabiome.环境 DNA 作为一种创新性技术，用于鉴定假冒抗疟药片的来源——对 Pharmabiome 的初步研究。
Sci Rep. 2022 Dec 20;12(1):21997. doi: 10.1038/s41598-022-25196-0.
5
Quality of Antimalarial Drugs in East Africa: A Systematic Review.东非抗疟药物的质量：一项系统评价。
Infect Drug Resist. 2022 Oct 21;15:6085-6092. doi: 10.2147/IDR.S373059. eCollection 2022.
6
A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR.老挝人民民主共和国假冒伪劣抗生素流行情况的随机调查。
J Antimicrob Chemother. 2022 May 29;77(6):1770-1778. doi: 10.1093/jac/dkab435.
7
Market Formation in a Global Health Transition.全球卫生转型中的市场形成
Environ Innov Soc Transit. 2021 Sep;40:40-59. doi: 10.1016/j.eist.2021.05.003.
8
Implementation of field detection devices for antimalarial quality screening in Lao PDR-A cost-effectiveness analysis.老挝人民民主共和国现场检测设备在抗疟质量筛查中的应用——成本效益分析。
PLoS Negl Trop Dis. 2021 Sep 30;15(9):e0009539. doi: 10.1371/journal.pntd.0009539. eCollection 2021 Sep.
9
Antimalarial Activity of Leaf Extracts in -Infected Mice.感染小鼠中叶提取物的抗疟活性。
Evid Based Complement Alternat Med. 2020 Feb 12;2020:8980212. doi: 10.1155/2020/8980212. eCollection 2020.
10
Poor-quality antimalarials further health inequities in Uganda.劣质抗疟药物进一步加剧了乌干达的健康不平等。
Health Policy Plan. 2019 Dec 1;34(Supplement_3):iii36-iii47. doi: 10.1093/heapol/czz012.
用于在环境条件下对露天材料进行分析的多功能新型离子源。
Anal Chem. 2005 Apr 15;77(8):2297-302. doi: 10.1021/ac050162j.
4
Artemisinin-based combination therapies for uncomplicated malaria.基于青蒿素的联合疗法治疗非复杂性疟疾。
Med J Aust. 2005 Feb 21;182(4):181-5. doi: 10.5694/j.1326-5377.2005.tb06650.x.
5
Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials.东南亚地区的假冒抗疟药是疟疾防控的主要障碍：关于假冒抗疟药流行情况的多国横断面调查
Trop Med Int Health. 2004 Dec;9(12):1241-6. doi: 10.1111/j.1365-3156.2004.01342.x.
6
Molecular epidemiology of malaria in Cameroon. XIX. Quality of antimalarial drugs used for self-medication.喀麦隆疟疾的分子流行病学。第十九部分：用于自我药疗的抗疟药物质量
Am J Trop Med Hyg. 2004 Mar;70(3):245-50.
7
Counterfeit artesunate antimalarials in southeast Asia.东南亚的假冒青蒿琥酯抗疟药。
Lancet. 2003 Jul 12;362(9378):169. doi: 10.1016/S0140-6736(03)13872-X.
8
Murder by fake drugs.假药致人死亡
BMJ. 2002 Apr 6;324(7341):800-1. doi: 10.1136/bmj.324.7341.800.
9
Authentication of artemether, artesunate and dihydroartemisinin antimalarial tablets using a simple colorimetric method.采用简单比色法对蒿甲醚、青蒿琥酯和双氢青蒿素抗疟片进行鉴别。
Trop Med Int Health. 2001 Dec;6(12):980-2. doi: 10.1046/j.1365-3156.2001.00793.x.
10
Fake artesunate in southeast Asia.东南亚的假冒青蒿琥酯。
Lancet. 2001 Jun 16;357(9272):1948-50. doi: 10.1016/S0140-6736(00)05085-6.